Target is struggling with weak sales, sending its shares sharply lower in 2025. RH's earnings outlook has been clouded by the ...

Market volatility continues to weigh on performance, forcing Rémy Cointreau to withdraw 2029-30 projections in favour of ...

Goldman Sachs lowered Tesla's target price citing weak deliveries in Europe and US. Tesla stock fell 14% on Thursday, wiping ...

The share price of Zydus Lifesciences has risen 0.13% in the past five trading sessions. The stock has given a return of 4.5% ...

Regardless of how any single quarter plays out, one of the best ways to evaluate a retailer like Target is by looking at how efficiently it generates returns in a capital-intensive business. Taking a ...

This is a great time to consider adding quality dividend stocks to your investment portfolio. Recent headwinds in the economy ...

Nvidia’s momentum exceeds expectations with 50% YoY growth guidance despite tariffs and new AI chips. Find out why NVDA stock ...

Elon Musk’s alliance with Donald Trump is unravelling, largely due to Trump’s “Big Beautiful Bill” that threatens to strip EV ...

Day One Biopharmaceuticals' Q1'25 sales grew modestly, but Q2 2025 earnings could spark movement. Read why I currently rate ...

Argentina's birth rate has declined by nearly 40% in the last decade, reaching its lowest level in more than 50 years in 2023 ...

The Motley Fool. DATE Thursday, June 5, 2025, at 4:30 p.m. ET CALL PARTICIPANTS Chief Executive Officer — Joel AndersonChief ...

In the current market climate, investors are increasingly shifting to defensive strategies. As investors navigate the ...